Margaret Hellard

HCV reinfection incidence among individuals treated for recent infection

G. Dore, K. Petoumenos, E. Gane, 2017, Journal of viral hepatitis.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

R. Peeling, Rakesh Aggarwal, S. Taylor-Robinson, 2019, The lancet. Gastroenterology & hepatology.

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.

J. Kaldor, G. Dore, K. Petoumenos, 2010, Drug and alcohol dependence.

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.

M. Hellard, S. Hutchinson, J. Grebely, 2014, The International journal on drug policy.

Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.

M. Hellard, L. Degenhardt, S. Kinner, 2015, Drug and alcohol dependence.

Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.

R Power, M Hellard, M. Hellard, 2009, Drug and alcohol dependence.

Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.

M. Hellard, E. Miller, S. Bowden, 2009, The Journal of infection.